Discovery of a novel VEGFR2 inhibitor using integrated structure-based docking study and functional validation: potential applications in targeted cancer therapy

Hussam Albassam; Saad Alobid; Faris Almutairi; Faisal Altowairqi

doi:10.1007/s44446-026-00072-4

Citations

388

Views

Abstract not available for this publication.

Cite this Article (APA)

Hussam, A., Saad, A., Faris, A., Faisal, A. (2026). Discovery of a novel VEGFR2 inhibitor using integrated structure-based docking study and functional validation: potential applications in targeted cancer therapy. Saudi Pharmaceutical Journal. https://doi.org/10.1007/s44446-026-00072-4

Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024

cites

396

Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems

Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024

cites

391

A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities

Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024

cites

394

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …